SHARPE
Reported results
- Total net product revenue was $259.7 million for the third quarter of 2026, representing 52% year-over-year growth.
- AUVELITY net product sales were $207.6 million for the third quarter of 2026, representing 53% year-over-year growth.
- SUNOSI net product revenue was $48.2 million for the third quarter of 2026, representing 47% year-over-year growth.
- Research and development (R&D) expenses were $50.6 million for the third quarter of 2026, compared to $40.2 million for the third quarter of 2025.
- Selling, general, and administrative (SG&A) expenses were $203.1 million for the third quarter of 2026, compared to $150.2 million for the third quarter of 2025.
- Net loss for the third quarter of 2026 was $12.9 million, or $(0.25) per share, compared to a net loss of $47.2 million, or $(0.94) per share, for the third quarter of 2025.
Guidance
- Axsome believes that its current cash is sufficient to fund anticipated operations into cash flow positivity, based on the current operating plan.
Price and volatility reaction
The stock moved -5.8% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -15.2 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 144.43 | 2026-10-30 |
| Close after release | 136.01 | 2026-11-02 |
| Realised move | -5.8% | close to close |
| 30d ATM IV change | -15.2 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-02 (8-K, Item 2.02). Read the original filing on sec.gov.